Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Surg ; 174(2): 160-3, 1997 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9293835

RESUMO

BACKGROUND: Flask pulmonary edema (FPE) may be a manifestation of renovascular hypertension (RVHTN) and unresponsive to antihypertensive therapy. METHODS: Response to antihypertensive therapy and perioperative outcomes were determined in 5 consecutive patients with FPE. RESULTS: A mean of 2.3 admissions for the treatment of FPE were observed despite a mean cardiac ejection fraction of 60%. Preoperative treatment was attempted for 12 days and included ventilatory support (n = 3) and hemodialysis (n = 2). Total decreased renal perfusion was demonstrated by arteriography and radionuclide scans, no patient having a functional, contralateral kidney. Renal revascularizations were not associated with mortalities; 1 patient experienced atalectasis requiring bronchoscopy. All patients were extubated within 48 hours of surgery. A significant reduction in blood pressure (BP, 46%) and serum creatinine (Cr, 53%, P < or = 0.05) was observed. A mean of 1 antihypertensive medication was required at discharge compared with 3.4 on admission. At follow-up (mean 57 months) all patients remain cured of FPE. CONCLUSIONS: Medical management was unsuccessful in the treatment of FPE. Renal revascularization was associated with low morbidity and mortality, control of BP, restoration of renal function, and cure of FPE. These data suggest surgical intervention is the optimal mode of treatment of RVHTN associated with FPE.


Assuntos
Hipertensão Renovascular/complicações , Edema Pulmonar/cirurgia , Idoso , Análise de Variância , Anastomose Cirúrgica , Aorta Abdominal/cirurgia , Prótese Vascular , Humanos , Artéria Ilíaca/cirurgia , Pessoa de Meia-Idade , Edema Pulmonar/etiologia , Artéria Renal/cirurgia , Estudos Retrospectivos , Veia Safena/transplante , Resultado do Tratamento , Procedimentos Cirúrgicos Vasculares/métodos
4.
Cancer ; 48(12): 2583-8, 1981 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-6796250

RESUMO

Fourteen patients with adenocarcinoma of the gastrointestinal tract and pancreas treated with mitomycin C(MMC) and 5-fluorouracil (5-FU) had renal impairment 6-11 months from the beginning of MMC therapy. Two clinical entities were recognized: an acute fulminating renal failure that was rapidly fatal and a chronic slowly progressive renal impairment. The first entity showed a microangiopathic hemolytic profile with anemia, thrombocytopenia, and erythrocyte fragmentation. Light microscopy and electron microscopy examination of the kidney revealed a primary vascular disease with musculomucoid intimal hyperplasia of arteries and rare fibrin thrombi in arterioles. Interstitial fibrosis, tubular atrophy, and widespread glomerular necrosis were also seen. The disease was ultimately fatal within three to four weeks. The second entity showed a chronic course of renal failure with similar pathologic findings but less pronounced, and a microangiopathic hemolysis was absent. The course in the second group was ultimately fatal between three to eight months.


Assuntos
Neoplasias Gastrointestinais/tratamento farmacológico , Nefropatias/induzido quimicamente , Rim/irrigação sanguínea , Mitomicinas/uso terapêutico , Injúria Renal Aguda/induzido quimicamente , Adenocarcinoma/tratamento farmacológico , Adulto , Idoso , Pressão Sanguínea , Nitrogênio da Ureia Sanguínea , Creatinina/sangue , Fluoruracila/uso terapêutico , Humanos , Rim/patologia , Rim/ultraestrutura , Nefropatias/mortalidade , Nefropatias/patologia , Falência Renal Crônica/induzido quimicamente , Pessoa de Meia-Idade , Mitomicina
5.
Arch Intern Med ; 141(11): 1556, 1981 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-7283577
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...